Table 1.
Characteristics | n = 506 |
Male/female | 251/255 |
Age at presentation (yr) | 31.5 ± 13.8 |
Median follow-up (yr) | 11.4 ± 7.8 |
Familial IBD | 12.9% |
Location (n) | |
L1 | 166 |
L2 | 182 |
L3 | 155 |
L4 only | 3 |
Behavior (n) | |
B1 | 288 |
At diagnosis B2 | 100 |
B3 | 118 |
Perianal disease | 25.5% |
Total steroid exposure/dependent-refractory | 68.6%/11.2% |
Total azathioprine exposure | 45.8% |
Total biological exposure | 9.1% |
Smoking habits (n) | |
No | 224 |
At diagnosis Ex | 38 |
Yes | 244 |
L1: Ileal; L2: Colonic; L3: Ileocolonic; L4: Upper Gastrointestinal; B1: Inflammatory; B2: Stenosing; B3: Penetrating. IBD: Inflammatory bowel disease.